HIMS Headwinds Ahead of Earnings

Raul Shah braves the snow and cold to join Morning Movers from the NYSE floor. He discusses Hims & Hers (HIMS) ahead of earnings. The company's faced multiple headwinds including legal issues from Novo Nordisk (NVO) and its sale of a semaglutide weight-loss product. Raul says the earnings call "will be crucial" for investors to get some clarity from the company's leaders and more insights on Hims & Hers next steps. Raul points to other markets like hormonal treatment as a potential growth area for HIMS.

Morning Movers

23 Feb 2026

SHARE

Schwab Network's Newsletters

Daily insights for every investor

ON AIR
10:00 am
Trading 360
12:00 am
The Wrap
REPLAY
12:30 am
Market On Close
REPLAY
2:00 am
Trading 360
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
ON AIR
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
10:00 pm
Trading 360
REPLAY
11:00 pm
The Wrap
REPLAY